Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001680
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
1999-11-03
Brief Title:
A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus
Status:
COMPLETED
Status Verified Date:
2000-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this double-masked pilot trial is to determine whether 20 percent thalidomide ointment is safe and effective for the treatment of chronic discoid lupus erythematosus CDLE when used under an occlusive dressing Seventeen patients with two similar lesions will have lesions randomized to receive either intervention or placebo therapy
Detailed Description:
The purpose of this double-masked pilot trial is to determine whether 20 thalidomide ointment is safe and effective for the treatment of chronic discoid lupus erythematosus CDLE when used under an occlusive dressing Seventeen patients with two similar lesions will have lesions randomized to receive either intervention or placebo therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 98-C-0008 | None | None | None |